Clinical Trials Logo

Clinical Trial Summary

To assess the short-term efficacy of stellate ganglion block on hot flush reduction versus sham procedure


Clinical Trial Description

Hot flushes are the most common symptom of menopause for which postmenopausal (PMP) women seek medical help, in 20% of PMP women hot flushes can persist for up to 15 years.

A possible treatment for hot flushes is stellate ganglion block (SGB), used as a means to interrupt parts of the sympathetic nervous system involved in temperature regulation.

Single centre randomized double blind placebo controlled intervention study Study period of 6 months in which patients will fill out on set time points 5 questionnaires regarding quality of life and keep a diary on hot flush frequency and severity during1 week on the same time points.

Study population:

Postmenopausal women aged 30-70 years old with no other causes of flushing present. Intervention (if applicable) Intervention: Stellate ganglion block versus sham procedure

Follow up with questionnaires during 6 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03756272
Study type Interventional
Source Rijnstate Hospital
Contact
Status Completed
Phase N/A
Start date September 1, 2017
Completion date February 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT02235051 - Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors N/A
Completed NCT01635413 - Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial) N/A
Completed NCT00701337 - Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route Phase 4
Recruiting NCT04705623 - Influence of Iyengar Yoga on the Bio-functional Age of Postmenopausal Women N/A
Withdrawn NCT03238703 - Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer Phase 4
Recruiting NCT03953157 - Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors N/A
Completed NCT00338728 - Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer Phase 2
Completed NCT01482702 - Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors N/A
Not yet recruiting NCT05009238 - Effect of l S Exercises on Balance and Spatiotemporal Gait Parameters in P M Women N/A
Recruiting NCT01842217 - Validation of [18F]FES for Imaging of Brain Estrogen Receptors N/A
Completed NCT01172574 - Motor Control Exercise in Osteoporotic Women N/A
Completed NCT00530582 - Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women Phase 4
Completed NCT01825785 - A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) Phase 1
Completed NCT04364061 - Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE) N/A
Completed NCT03180294 - Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer Phase 2
Completed NCT01753908 - Broccoli Sprout Extract in Treating Patients With Breast Cancer Early Phase 1
Recruiting NCT06228768 - Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer N/A
Terminated NCT01294397 - Effects of Denosumab on the Pharmacokinetics of Etanercept Phase 1
Completed NCT00603967 - Effect of Aromatase Inhibitors on Bones and Genes N/A
Completed NCT00918398 - AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations Phase 1